METABOLISM IN CANCER AND AGING

Our lab focuses on studying the metabolic features of aggressive lymphomas with poor outcomes, specifically those involving MYC and BCL2 alterations. We aim to identify new metabolic vulnerabilities in these tumors using advanced tools and patient samples, potentially leading to targeted therapies beyond current options.